SEOUL, Sept 24 (Reuters) - South Korea's drug watchdog

said on Tuesday it would seek information from relevant

companies after a U.S. government announcement on Tylenol,

adding that it planned to review opinions and documents they

provided.

On Monday, President Donald Trump linked autism to childhood

vaccine use and the use of popular pain medication Tylenol by

pregnant women, elevating to the forefront of U.S. health policy

claims unsupported by scientific evidence.